The purpose of this pictorial essay was to discuss and illustrate computed tomography and magnetic resonance enterography findings in patients with Crohn's disease. These noninvasive and easily performed methods for the evaluation of Crohn's disease are useful for differentiating between active and fibrotic bowel disease, and can help to guide treatment (medical vs surgical). Although inflammatory and fibrostenotic findings of Crohn's disease may overlap, computed tomography and magnetic resonance enterography can help to identify the presence, extent, and severity of active inflammation that may respond to medical therapy, and the existence of fistulas and fibrostenosis that may benefit from surgical management.
Computed tomography enterography (CTE) and magnetic resonance enterography (MRE) are the main imaging methods used to diagnose, stage, and monitor small bowel Crohn's disease. These methods are used to evaluate transmural pathologic changes and extraluminal complications [1e3]. Crohn's disease has a wide spectrum of presentation and is often associated with active inflammation and fibrosis [4e6] . Imaging findings that indicate active inflammation include mural thickening, submucosal oedema, contrast enhancement, prominent vasa recta, mesenteric oedema, and reactive lymphadenopathy. Other findings suggest fibrostenotic disease, such as wall thickening, with hypointense T1 and T2 signal intensity with no or slight inhomogeneous enhancement that becomes more prominent in a delayed phase [1, 3, 7] . Fistulous tracts and abscess characterize the penetrating form of the disease [1, 3, 8] .
This pictorial essay reviews the CTE and MRE findings of patients with Crohn's disease by highlighting patterns that aid in the characterization of active inflammation, fistulas, and fibrostenosis. The proper identification of these patterns will enable the clinician to select the most appropriate treatment (clinical or surgical). Techniques CTE and MRE are performed after the distention of the small bowel with a large volume of neutral contrast agent (1500-2000 mL) given orally 40-60 minutes before the examination [1e3]. Polyethylene glycol electrolyte solution, 3% mannitol, and 0.1% wt/vol low-concentration barium with sorbitol (Volumen; E-Z-EM, Westbury, NY) are available as oral contrast agents. Patients undergoing CTE or MRE are requested to abstain from all food and drink for 4 hours before scanning [9] .
CTE
Neutral CTE oral contrast allows proper evaluation of small bowel mural enhancement. Single-phase scanning is performed from the diaphragm to the pubic symphysis during the enteric phase, 45 seconds after the beginning of intravenous contrast material injection (100-150 mL) at a rate of 3-4 mL/s. Images are acquired with a section thickness of 2.0-2.5 mm and a reconstruction interval of 1.0-1.5 mm. Multiplanar reformatting helps the characterization of enteric and extraenteric abnormalities [3, 9] .
MRE
The most commonly used MRE enteric contrasts are the biphasic agents, which have low signal intensity on T1-weighted images (T1WI) and high signal intensity on T2-weighted images (T2WI). The low signal intensity of these agents on T1WI improves the contrast between bowel lumen and the inflamed hyperenhancing bowel wall after intravenous contrast material administration. The use of spasmolytics agents, such as hyoscine butylbromide and glucagon, are useful for reducing bowel peristalsis and motion artifacts [1, 10] .
The MRE protocol includes a combination of axial and coronal T2 half-Fourier acquisition single-shot turbo spinecho (HASTE) (single-shot fast spin-echo [SSFSE]) with and without fat suppression, balanced steady-state free precession (SSFP)(True fast imaging with steady-state precession [TrueFISP]) images, and pree and postecontrast-enhanced gradient-echo T1 3-dimensional sequences. T2 HASTE (SSFSE) sequences best demonstrate focal wall thickening, fold pattern changes, and ulceration but are susceptible to intraluminal motion and are often associated with intraluminal low-signal-intensity artifacts. Balanced SSFP (TrueFISP) images best depict mesenteric adenopathy and prominent vasa recta in active Crohn's disease (''comb sign'') but are prone to susceptibility artifacts when air is present within the bowel lumen. Fat suppression may be added for better detection of wall and mesenteric oedema as well as for differentiation of focal submucosal fatty infiltration from oedema. Postcontrast imaging is a very important part of the examination, performed 30, 70, and 90 seconds after gadolinium intravenous injection (2 mL/s) and allows the assessment of bowel wall, nodal, and fistulas enhancement [1, 10, 11] .
MRE and CTE have comparable accuracy in the evaluation of Crohn's disease [1] . The lack of ionizing radiation is a major advantage of MRE over CTE, especially when considering the young age of patients with Crohn's disease, who will require multiple examinations during their lifetimes [7, 11] . The superior tissue contrast of MRE may also allow differentiation among various pathologic changes in the bowel wall that may show nonspecific low attenuation on CTE images. In addition, MRE uses a safer venous contrast agent. However, CTE has higher temporal and spatial resolution, a shorter imaging time, less variability in examination quality, and easy availability and lower cost [1,3,10,11]. 
Imaging Findings

Bowel-Wall Abnormalities
Bowel-wall thickening
Both active inflammatory and fibrostenotic Crohn's disease usually present with bowel-wall thickening (>3 mm), a finding with high sensitivity and specificity for this disease (83%-91% and 86%-100%, respectively) ( Figure 1 ) [2, 8, 10, 12, 13] .
Submucosal oedema
Submucosal oedema usually represents active inflammatory Crohn's disease and manifests as nonspecific low attenuation on CTE images and high T2 signal intensity on MRE images. Oedema is more conspicuous on fatsuppressed images ( Figure 2) [3, 4, 8, 12] .
Fat wall infiltration (fat halo sign)
The presence of submucosal fat deposition in the bowel wall is a sign of chronic Crohn's disease. On CTE images, such infiltration appears as very low attenuation (fat density) ( Figure 3 ). On MRE, it is seen as high T2 signal intensity on nonefat-suppressed images that loses signal intensity on fatsuppressed images ( Figure 4 ) [3, 8, 14] .
Fibrosis
Fibrotic wall thickening appears as nonspecific low attenuation on CTE images and has low T1 and T2 signal intensity on MRE images. Both imaging methods show no enhancement or slight progressive enhancement that becomes more prominent in a very delayed phase (8 minutes) ( Figure 5 ) [3, 7, 8, 15] . Patients who present with this feature in addition to clinically significant stenosis are candidates for surgical intervention [16] .
Contrast enhancement
Mural enhancement is the most-sensitive indicator of active Crohn's disease [1e3] . Three different enhancement patterns have been described in Crohn's disease: homogeneous, layered (stratified), and mucosal enhancement. The homogeneous pattern is characterized by diffuse enhancement of the entire wall thickness. Stratified enhancement shows mucosal, relatively poor submucosal, and serosal enhancement, which creates a target-like appearance in cross-sectional imaging. In the mucosal pattern, enhancement of the innermost layer of the bowel wall is observed ( Figure 6 ). In Crohn's disease, all contrast-enhancement patterns are associated with active inflammation when compared with histopathologic findings and may be associated with fibrotic changes. Patients with fibrotic changes in the bowel wall often have coexistent active inflammation [4e7,13] . Although stratified enhancement has been reported to show a higher correlation with active inflammation than other enhancement patterns [6, 8] , the clinical significance of each enhancement pattern has not been well established in the literature [13] . The absence of enhancement is useful for the exclusion of disease activity [15] .
Skip Lesions
Patients with Crohn's disease frequently have multiple involved small bowel segments separated by healthy bowel, which are referred to as skip lesions ( Figure 7) [1,3,10,14]. 
Bowel-Wall Stenosis and Bowel Obstruction
Bowel-wall stenosis in Crohn's disease is invariably associated with a segment of thickened bowel wall, whereas adhesive strictures do not demonstrate this finding [10] and can be due to active inflammation (Figure 8 ). This differentiation is crucial to the choice of therapy. Disease activity can be suggested by oedema, mucosal ulceration, and contrast enhancement. Although this distinction is very important, it is not always clear on imaging studies [16] . When a prestenotic dilatation of >3 cm is present, the disease is probably chronic and clinically significant [4e6].
Prominent Vasa Recta (Comb Sign)
Prominent vasa recta are caused by increased mesenteric vascularity during active inflammation. The vessels penetrate the bowel wall perpendicular to the affected bowel lumen and are seen as parallel lines that enhance after contrast administration (Figure 9) [1e3,10].
Mesenteric Oedema
Mesenteric oedema is seen as increased attenuation of the mesenteric fat on CTE images and high T2 signal intensity on fat-suppressed MRE images, which corresponds to active disease in the bowel wall ( Figure 10) [3,7,10] .
Ulcerations
Moderate and deep ulcerations appear as areas of mural irregularity on postcontrast CTE or MRE, and on T2-weighted images ( Figure 11 ) [1, 8, 10, 14] . The reported sensitivity of MRE for the diagnosis of ulcers is 56%-90% [8, 13] . 
Sinuses and Fistulas
Sinuses (Figure 12 ) and fistulas indicate active disease and are seen as high-attenuation lines on CTE images and T2 hyperintense lines that enhance after contrast administration, which reflect their higher vascular flow and hyperemia [8] . Complex internal fistulas usually have a stellate appearance, with multiple tracts and bowel loops that radiate from the central portion that are associated with desmoplastic and fibrotic reactions in the surrounding mesentery. Fistulas in Crohn's disease can be enteroenteric and enterocolonic (Figure 13 ), enterovesical ( Figure 14 ), enterocutaneous ( Figure 15 ), and perianal [1, 4, 10] . The reported sensitivity of MRE and CTE for the detection of internal fistulas is 83% and the specificity is 100% [8] .
Abscesses
Abscesses are seen as hyperintense on T2W MRE imaging, with a corresponding hypodense appearance on CT, with a capsule that enhances after contrast administration ( Figure 16 ) [1, 8, 10] . These features are a sign of active disease [4] .
Pseudodiverticulum Formation
Pseudodiverticulum is the apparent dilatation of the antimesenteric border of the bowel wall. This condition occurs as a consequence of fibrosis of the diseased mesenteric side and is usually associated with other signs of chronic disease ( Figure 17) [8, 10] .
Fibrofatty Proliferation
Fibrofatty proliferation occurs as increased mesenteric fat surrounding chronically inflamed bowel loops and is a sign of chronic disease ( Figure 18) [1, 2, 8] .
Reactive Lymphadenopathy
Reactive lymphadenopathy commonly occurs in association with active inflamed bowel loops [1, 5, 8] .
Pitfalls
Fat wall infiltration, oedema, and fibrosis
Abnormalities such as fatty wall infiltration, oedema, and fibrosis appear as nonspecific low attenuation on CTE and are more readily characterized by MRE because of its higher tissue contrast differentiation [3,7,10]. 
Inadequate bowel distention
Inadequate bowel distention is an important problem that can affect the assessment of wall thickness and enhancement. Nondistended loops can simulate or mask disease [3, 10, 11, 14] .
Conclusion
CTE and MRE are powerful tools in the management of Crohn's disease that can demonstrate small bowel mucosal and mural inflammation as well as diagnose extraluminal complications. Mural thickening, submucosal oedema, wall enhancement, fat stranding, reactive lymphadenopathy, and engorgement of the vasa recta characterize active disease. Fibrostenotic disease is seen as nonspecific wall hypodensity on CTE and as mural hypointense signaling on T1-and T2-weighted images, with a lack of enhancement or progressive delayed enhancement. Findings that indicate long-standing Crohn's disease include submucosal fat deposition, pseudodiverticula, fibrofatty proliferation, and fibrotic strictures. CTE and MRE can also help to identify the predominant disease type (active inflammatory or fibrostenotic) and to guide and monitor treatment (medical vs surgical). . Note also ileal segments that display wall thickening and mural hyperenhancement, mainly in the mucosa (arrowheads). A complex ileocolonic fistula was also noted in this patient (not shown).
